Baird Financial Group, Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$706,391
-54.0%
61,586
+1.5%
0.00%
-50.0%
Q2 2023$1,534,950
-22.6%
60,646
-1.5%
0.00%
-20.0%
Q1 2023$1,983,267
+180197.0%
61,573
+3.4%
0.01%
+66.7%
Q4 2022$1,100
-99.9%
59,560
+0.9%
0.00%
-40.0%
Q3 2022$1,594,000
+17.9%
59,044
+21.7%
0.01%
+66.7%
Q3 2021$1,352,000
+16.9%
48,515
+24.3%
0.00%0.0%
Q2 2021$1,157,000
+51.8%
39,027
+43.1%
0.00%
+50.0%
Q1 2021$762,000
+57.4%
27,267
+41.7%
0.00%0.0%
Q3 2020$484,000
+26.0%
19,244
+22.3%
0.00%
+100.0%
Q2 2020$384,000
-70.1%
15,741
-83.3%
0.00%
-91.7%
Q2 2016$1,283,000
-30.8%
94,308
-11.3%
0.01%
-33.3%
Q1 2016$1,855,000
-34.3%
106,265
+28.6%
0.02%
-35.7%
Q4 2015$2,822,000
+36.5%
82,610
+18.9%
0.03%
+27.3%
Q3 2015$2,068,000
+89.2%
69,496
+103.3%
0.02%
+100.0%
Q2 2015$1,093,00034,1810.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders